Discontinued — last reported Q4 '25
Investing
Business Sale Proceeds
Year-over-year, this metric declined by 100.0%, from $250.00K to $0.00. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows a downward trend with a -100.0% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2025
How to read this metric
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
Detailed definition
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Peer comparison
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
Metric ID:
cf_proceeds_from_sale_of_businessHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $134.00M | $48.00M | $40.00M | $1.00M | $0.00 |
| YoY Change | — | -64.2% | -16.7% | -97.5% | -100.0% |
Range$0.00 – $134.00M
CAGR-100.0%
Avg YoY Growth-69.6%
Median YoY Growth-80.8%
Current Streak4+ years decline
Business Sale Proceeds at Other Companies
Frequently Asked Questions
- What is Abbott's business sale proceeds?
- Abbott (ABT) reported business sale proceeds of $0.00 in Q4 2025.
- How has Abbott's business sale proceeds changed year-over-year?
- Abbott's business sale proceeds decreased by 100.0% year-over-year, from $250.00K to $0.00.
- What is the long-term trend for Abbott's business sale proceeds?
- Over 4 years (2021 to 2025), Abbott's business sale proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $134.00M to $0.00.
- What does business sale proceeds mean?
- Cash received from selling off parts of the business.